AMPH: Amphastar Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 942.52
Enterprise Value ($M) 942.13
Book Value ($M) 389.40
Book Value / Share 8.25
Price / Book 2.43
NCAV ($M) 116.92
NCAV / Share 2.48
Price / NCAV 8.11

Profitability (mra)
Return on Invested Capital (ROIC) -0.02
Return on Assets (ROA) -0.01
Return on Equity (ROE) -0.02

Liquidity (mrq)
Quick Ratio 1.84
Current Ratio 3.11

Balance Sheet (mrq) ($M)
Current Assets 268.90
Assets 585.64
Liabilities 151.98
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 294.67
Operating Income -8.62
Net Income -6.66
Earnings Per Share Diluted -0.12
Earnings Per Share Basic -0.12

Cash Flow Statement (mra) ($M)
Cash From Operations 38.19
Cash from Investing -42.18
Cash from Financing -42.18

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2019-02-13 13G/A Zhang Jack Y. 27.30 3.74
2019-01-24 13G/A BlackRock Inc. 12.90 7.47
2015-02-17 13G/A Broadfin Capital, LLC 4.80

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2019-11-08 10-Q AMPH / Amphastar Pharmaceuticals, Inc. 10-Q – Quarterly Report – 10-Q
2019-08-09 10-Q AMPH / Amphastar Pharmaceuticals, Inc. 10-Q – Quarterly Report – 10-Q
2019-05-10 10-Q AMPH / Amphastar Pharmaceuticals, Inc. 10-Q Quarterly Report 10-Q
2019-03-15 10-K AMPH / Amphastar Pharmaceuticals, Inc. 10-K (Annual Report)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-01-16 9,844 164,900 5.97
2020-01-15 22,337 279,900 7.98
2020-01-14 8,448 305,500 2.77
2020-01-13 17,212 170,500 10.10

(click for more detail)

Similar Companies
AMAG – AMAG Pharmaceuticals, Inc. AMBI – Ambit Biosciences Corp
AMGN – Amgen Inc. AMRN – Amarin Corp. Plc
ANAC – Anacor Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io